Eurosurveillance banner
HOME
ARCHIVES
ABOUT US
Editorial policy
For Authors
Links

Advanced search

Eurosurveillance RSS RSS Feed
Eurosurveillance subscribe Subscribe
Eurosurveillance unsubscribe Unsubscribe
Contact Eurosurveillance Contact
Sitemap Sitemap
Call for papers for a special issue on HIV/AIDS and other sexually transmitted infections in men who have sex with men
Eurosurveillance invites authors to submit papers for a special issue on HIV/AIDS and other sexually transmitted infections (STI) in men who have sex with men (MSM). The topic is in line with the main theme of World AIDS Day 2009 events organised by the European Centre for Disease Prevention and Control and aims at drawing attention to the epidemiological importance of MSM in HIV and other STI and directing the ECDC activities to focus on main risk groups.
Call for papers – Eurosurveillance special issue on socio-economic determinants and infectious diseases in Europe. Deadline extended until 15 November
Eurosurveillance is planning to publish a special issue on Socio-economic determinants and infections diseases in Europe in spring 2010. For this reason Eurosurveillance invites interested scientists who have research findings in the area to submit papers for review and possible publication. The submission deadline now is 15 November.
Eurosurveillance publishes new EU-wide data on tuberculosis
The data from 27 European Union countries plus Iceland, Liechtenstein and Norway show that considerable progress has been made in preventing and controlling the disease. The number of newly diagnosed cases and the overall notification rate declined continuously in the past decade, and the notification rate in 2007 was 12% lower than in 2003. In spite of this decline, a total of 84,917 new cases of TB were registered in 2007 and a number of challenges hamper the progress towards the elimination of TB in the EU.
Special issue on pregnancy and infectious diseases
A number of bacterial and viral infections in pregnant women can have serious effects on the unborn child leading to impaired mental and physical health later in life. This week’s issue of Eurosurveillance is dedicated to infectious diseases in pregnancy.
Special issues on antimicrobial resistance
The emergence and spread of antimicrobial resistance (AMR) is a growing problem in many European countries. To mark the very first European Antibiotic Awareness Day, on 18 November, the scientific journal Eurosurveillance runs a series of articles to highlight main aspects of the AMR problem in Europe. They will be published in two issues on 13 and 20 November 2008.
Special issue on seasonal influenza vaccination
In preparation for the coming influenza season 2008-9, Eurosurveillance publishes a special issue on prevention of influenza by vaccination. Seasonal influenza poses a serious public health threat because of associated serious morbidity and mortality. In Europe, estimates suggest that influenza is responsible for around 40,000 to 220,000 excess deaths, depending on the severity of the epidemic.
STARHS (Serological Testing Algorithms for Recent HIV Seroconversion) - progress towards estimating new HIV infections in Europe
Today Eurosurveillance is publishing a special issue dedicated to the widespread advances made in Europe in estimating the real number of newly acquired HIV infections based on an innovative approach called STARHS
Eurosurveillance publishes a special issue on hepatitis B and C
To tie in with World Hepatitis Day on 19 May, the scientific journal Eurosurveillance is today publishing a special issue on viral hepatitis, highlighting issues and challenges related to hepatitis B and C.
Immunisation Week
On 17 April 2008, Eurosurveillance is publishing a special issue with articles on the measles situation in Europe. The publication is linked to European Immunisation Week which runs from 21-27 April.
Eurosurveillance publishes special issue on tuberculosis
World Tuberculosis Day on 24 March commemorates the date in 1882 when Robert Koch presented his findings of the causing agent of tuberculosis (TB) – Mycobacterium tuberculosis. In the run up of this day Eurosurveillance publishes a special issue on the situation of TB in Europe.
Special issue on meningococcal disease
Today (6 March, 2008), Eurosurveillance, the European peer-reviewed journal of infectious diseases, publishes a special issue on meningococcal disease. It includes two in-depth articles and an editorial by the European Centre for Disease Prevention and Control (ECDC).
View all press releases All press releases
In this issue
Observed oseltamivir resistance in seasonal influenza viruses in Europe interpretation and potential implications
Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe
Public health response to an avian influenza A (H5N1) poultry outbreak in Suffolk, United Kingdom, in November 2007
Continuing importation of falciparum malaria from Goa into Europe
In the national bulletins


Home Eurosurveillance Edition  2008: Volume 13/ Issue 5 Article 4 Printer friendly version
Back to Table of Contents
Previous Download (pdf) Next
Eurosurveillance, Volume 13, Issue 5, 31 January 2008
Rapid communications
Continuing importation of falciparum malaria from Goa into Europe
T Jelinek ()1, on behalf of the European Network on Imported Infectious Disease Surveillance (TropNetEurop)
  1. Berlin Center for Travel & Tropical Medicine, Berlin, Germany
Citation style for this article: Jelinek T, on behalf of the European Network on Imported Infectious Disease Surveillance (TropNetEurop) . Continuing importation of falciparum malaria from Goa into Europe. Euro Surveill. 2008;13(5):pii=8028. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=8028

 

A case of falciparum malaria acquired in Goa, India, has recently been reported to the European Network on Imported Infectious Disease Surveillance (TropNetEurop, http://www.tropnet.net). The report relates to a Swedish woman in her fifties who had spent two weeks in Goa (Candolim beach) and Kerala in India without taking malaria chemoprophylaxis. In mid-December 2007, approximately two weeks after returning to Sweden, she fell ill with fever and a mild cough. Ten days after the onset of symptoms, thick and thin films were done and an infection with Plasmodium falciparum with a parasitaemia of 1.8% was diagnosed. The patient was admitted to hospital, uneventfully treated with a standard dose of mefloquine and discharged four days later.

This case report provides more evidence of the continuing risk of falciparum malaria infection in Goa. A popular winter resort for European tourists, Goa was until last year considered an area of very low-risk of malaria infection for travellers. However, during the 2006-7 winter season, eight cases of P. falciparum cases among tourists returning from Goa were reported to TropNetEurop, whereas in the previous two years there had been no reports of malaria in European travellers to this area [1]. An increased incidence among the indigenous population was also confirmed by local authorities.

Since December 2006, 19 malaria cases imported from India have been reported, among which 13 were explicitly identified as coming from Goa. The cluster of eight cases reported in the winter of 2006-7 coincided with a period of intense rainfall (50% above average) in the Goan and Konokan region, which had begun in October 2006 [2]. However, reports of malaria cases imported from Goa have continued despite changes in the season and the amount of rainfall. Since last winter, five more cases have been reported over a period of several months, including the most recent one described above.

It appears that there may be a continuously increased risk of malaria transmission. TropNetEurop has therefore been recommending malaria chemoprophylaxis to all travellers to Goa since 2007 [3]. All tourists who intend to visit this region of India are also advised to use mosquito bite avoidance measures. Visitors may consider using the World Health Organization’s type IV prevention [4], which is mosquito bite prevention plus chemoprophylaxis with atovaquone/proguanil, doxycycline, or mefloquine, or they may consider travelling with emergency standby treatment. Anyone who becomes unwell while on holiday or shortly after their return should seek immediate medical attention. Falciparum malaria can be a life-threatening illness. The diagnosis can only be made if a careful travel history is taken, and testing done early, even for regions where malaria is not normally recognised.

 

References

  1. TropNetEurop Friends & Observers Sentinel Surveillance Report: November 2006. Map on p. 3. Available at: http://www.tropnet.net/reports_friends/pdf_reports_friends/nov06_dengue2006_friends.pdf
  2. Rainfall maps, India Meteorological Department. http://www.imd.ernet.in/section/hydro/dynamic/seasonal-rainfall.htm
  3. Jelinek T, Behrens R, Bisoffi Z, Bjorkmann A, Andersen P, Blaxhult A, et al. Recent cases of falciparum malaria imported to Europe from Goa, India, December 2006-January 2007. Euro Surveill 2007;12(1):E070111.1. Available from: http://www.eurosurveillance.org/ew/2007/070111.asp#1
  4. Country list; Vaccination requirements and malaria situation. In: International travel and health publication. Geneva: World Health Organization; 2005. http://whqlibdoc.who.int/publications/2005/9241580364_country_list.pdf

 


Back to Table of Contents
Previous Download (pdf) Next
Disclaimer:The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the Editorial team or the institutions with which the authors are affiliated. Neither the ECDC nor any person acting on behalf of the ECDC is responsible for the use which might be made of the information in this journal.
The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our Website does not host any form of commercial advertisement.

Eurosurveillance [ISSN] - ©2008 All rights reserved
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.